Target Gene/Pathway(薬物標的遺伝子/パスウェイリスト)💬 Info on mouse-over

87 / 286 pathways

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Adherens junction 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
2 Adipocytokine signaling pathway 💬
3件: CPT1A, CPT1B, CPT1C 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
3 Adipocytokine signaling pathway 💬
3件: CPT1A, CPT1B, CPT1C 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
4 Adrenergic signaling in cardiomyocytes 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
5 Adrenergic signaling in cardiomyocytes 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
6 Aldosterone synthesis and secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
7 Aldosterone synthesis and secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
8 Alzheimer disease 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
9 Alzheimer disease 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
10 Amphetamine addiction 💬
2件: CACNA1C, CACNA1D 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
11 Amphetamine addiction 💬
2件: CACNA1C, CACNA1D 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
12 AMPK signaling pathway 💬
3件: CPT1A, CPT1B, CPT1C 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
13 AMPK signaling pathway 💬
3件: CPT1A, CPT1B, CPT1C 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
14 Arrhythmogenic right ventricular cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
15 Arrhythmogenic right ventricular cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
16 Axon guidance 💬
2件: ABL1, SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
17 Bacterial invasion of epithelial cells 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
18 Bladder cancer 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
19 C-type lectin receptor signaling pathway 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
20 Calcium signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
21 Calcium signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
22 cAMP signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
23 cAMP signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
24 Carbohydrate digestion and absorption 💬
1件: CACNA1D 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
25 Carbohydrate digestion and absorption 💬
1件: CACNA1D 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
26 Cardiac muscle contraction 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
27 Cardiac muscle contraction 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
28 Cell cycle 💬
1件: ABL1 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
29 Cellular senescence 💬
1件: CACNA1D 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
30 Cellular senescence 💬
1件: CACNA1D 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
31 cGMP-PKG signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
32 cGMP-PKG signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
33 Chemokine signaling pathway 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
34 Cholinergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
35 Cholinergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
36 Chronic myeloid leukemia 💬
1件: ABL1 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
37 Circadian entrainment 💬
2件: CACNA1C, CACNA1D 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
38 Circadian entrainment 💬
2件: CACNA1C, CACNA1D 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
39 Cortisol synthesis and secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
40 Cortisol synthesis and secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
41 Cushing syndrome 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
42 Cushing syndrome 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
43 Diabetic cardiomyopathy 💬
2件: CPT1B, CPT2 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
44 Diabetic cardiomyopathy 💬
2件: CPT1B, CPT2 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
45 Dilated cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
46 Dilated cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
47 Dopaminergic synapse 💬
2件: CACNA1C, CACNA1D 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
48 Dopaminergic synapse 💬
2件: CACNA1C, CACNA1D 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
49 EGFR tyrosine kinase inhibitor resistance 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
50 Endocrine resistance 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
51 Endocytosis 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
52 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
53 ErbB signaling pathway 💬
2件: ABL1, SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
54 Estrogen signaling pathway 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
55 Fatty acid degradation 💬
4件: CPT1A, CPT1B, CPT1C, CPT2 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
56 Fatty acid degradation 💬
4件: CPT1A, CPT1B, CPT1C, CPT2 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
57 Fatty acid metabolism 💬
4件: CPT1A, CPT1B, CPT1C, CPT2 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
58 Fatty acid metabolism 💬
4件: CPT1A, CPT1B, CPT1C, CPT2 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
59 Fluid shear stress and atherosclerosis 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
60 Focal adhesion 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
61 GABAergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
62 GABAergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
63 GABAergic synapse 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
64 Gap junction 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
65 Glucagon signaling pathway 💬
3件: CPT1A, CPT1B, CPT1C 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
66 Glucagon signaling pathway 💬
3件: CPT1A, CPT1B, CPT1C 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
67 Glutamatergic synapse 💬
2件: CACNA1C, CACNA1D 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
68 Glutamatergic synapse 💬
2件: CACNA1C, CACNA1D 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
69 GnRH secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
70 GnRH secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
71 GnRH signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
72 GnRH signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
73 GnRH signaling pathway 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
74 Growth hormone synthesis, secretion and action 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
75 Growth hormone synthesis, secretion and action 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
76 Hepatitis B 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
77 Herpes simplex virus 1 infection 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
78 Human cytomegalovirus infection 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
79 Hypertrophic cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
80 Hypertrophic cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
81 Inflammatory mediator regulation of TRP channels 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
82 Insulin resistance 💬
2件: CPT1A, CPT1B 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
83 Insulin resistance 💬
2件: CPT1A, CPT1B 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
84 Insulin secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
85 Insulin secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
86 Kaposi sarcoma-associated herpesvirus infection 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
87 Long-term potentiation 💬
1件: CACNA1C 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
88 Long-term potentiation 💬
1件: CACNA1C 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
89 MAPK signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
90 MAPK signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
91 MicroRNAs in cancer 💬
1件: ABL1 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
92 Mitophagy - animal 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
93 Neurotrophin signaling pathway 💬
1件: ABL1 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
94 Neutrophil extracellular trap formation 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
95 Oxytocin signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
96 Oxytocin signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
97 Oxytocin signaling pathway 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
98 Pathogenic Escherichia coli infection 💬
2件: ABL1, SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
99 Pathways in cancer 💬
1件: ABL1 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
100 Pathways of neurodegeneration - multiple diseases 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
101 Pathways of neurodegeneration - multiple diseases 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
102 Platelet activation 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
103 PPAR signaling pathway 💬
4件: CPT1A, CPT1B, CPT1C, CPT2 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
104 PPAR signaling pathway 💬
4件: CPT1A, CPT1B, CPT1C, CPT2 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
105 Prion disease 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
106 Prion disease 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
107 Prolactin signaling pathway 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
108 Proteoglycans in cancer 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
109 Rap1 signaling pathway 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
110 Ras signaling pathway 💬
1件: ABL1 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
111 Regulation of actin cytoskeleton 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
112 Relaxin signaling pathway 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
113 Renin secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
114 Renin secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
115 Retrograde endocannabinoid signaling 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
116 Retrograde endocannabinoid signaling 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
117 Serotonergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
118 Serotonergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
119 Shigellosis 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
120 Taste transduction 💬
1件: CACNA1C 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
121 Taste transduction 💬
1件: CACNA1C 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
122 Thermogenesis 💬
4件: CPT1A, CPT1B, CPT1C, CPT2 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
123 Thermogenesis 💬
4件: CPT1A, CPT1B, CPT1C, CPT2 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
124 Thyroid hormone signaling pathway 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
125 Tight junction 💬
1件: CACNA1D 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
126 Tight junction 💬
1件: CACNA1D 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
127 Tight junction 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
128 Tuberculosis 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
129 Type II diabetes mellitus 💬
2件: CACNA1C, CACNA1D 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
130 Type II diabetes mellitus 💬
2件: CACNA1C, CACNA1D 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
131 Vascular smooth muscle contraction 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D05442 💬 Perhexiline 2件: 58, 272 💬
132 Vascular smooth muscle contraction 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D08340 💬 Perhexiline 2件: 58, 272 💬
133 VEGF signaling pathway 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
134 Viral carcinogenesis 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
135 Viral myocarditis 💬
1件: ABL1 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬
136 Yersinia infection 💬
1件: SRC 💬 D09664 💬 Saracatinib 3件:  6 , 89, 272 💬